+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06203847

A Randomized Trial Comparing Epinephrine Alone to Epinephrine with Vasopressin and Steroid for Adults with Out-of-Hospital Cardiac Arrest in Taipei

Led by National Taiwan University Hospital · Updated on 2025-11-19

1344

Participants Needed

1

Research Sites

21 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effects of different drug treatments on adult patients who suffer sudden non-traumatic out-of-hospital cardiac arrest OHCA and are resuscitated by advanced paramedics in Taipei City and New Taipei City. The study compares a combination therapy of epinephrine, vasopressin, and methylprednisolone against standard epinephrine treatment alone to see which improves sustained recovery of spontaneous circulation ROSC and long-term survival. This randomized clinical trial, called the OHCA-REVIVES trial, aims to find the best prehospital medication strategy to improve survival outcomes after OHCA. The trial includes two groups the intervention group receives combined drug treatment with epinephrine every 3-5 minutes, vasopressin every 3-5 minutes up to 80 units total, and one dose of methylprednisolone after the first epinephrine dose. The control group receives standard treatment with epinephrine every 3-5 minutes only. These medications are administered before hospital arrival by paramedics trained in the trial procedures. The study expects to enroll approximately 1,344 patients over about 30 months. Participants are assessed for the primary outcome of sustained ROSC lasting about 2 hours, along with secondary outcomes including prehospital ROSC, survival to hospital discharge, and survival with good neurological status up to 30 days. Data collection occurs during prehospital care and hospital stay. The study follows patients to evaluate the effects of the drug treatments on recovery and survival after cardiac arrest. Enrollment started in mid-2024 and is expected to continue until the end of 2026.

CONDITIONS

Brief Title

The Effect of Prehospital Combination of Epinephrine, Vasopressin, and Steroid in OHCA

Research Team

W

WEN CHU CHIANG, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here